Stay updated on HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T19:13:11.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T15:00:58.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Administrative updates include adding Revision: v3.4.2 and removing a government funding status notice as well as Revision: v3.4.1; these changes do not affect the study details, eligibility criteria, or results information.
    Difference
    0.4%
    Check dated 2026-02-11T20:35:39.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and NIH operations was added, and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T11:18:47.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The updates are UI labeling and metadata changes: a new 'Show glossary' option was added and QC-related labels were adjusted (e.g., capitalization of 'Met QC Criteria'). The revision/version was updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T07:24:28.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page, with no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:40:06.000Z thumbnail image

Stay in the know with updates to HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.